Analysing data and undertaking meta‐analyses

[1]  Jack Bowden,et al.  A comparison of heterogeneity variance estimators in simulated random‐effects meta‐analyses , 2018, Research synthesis methods.

[2]  Orestis Efthimiou,et al.  Practical guide to the meta-analysis of rare events , 2018, Evidence Based Journals.

[3]  Julian P T Higgins,et al.  A re‐evaluation of fixed effect(s) meta‐analysis , 2018 .

[4]  Dean Langan,et al.  Comparative performance of heterogeneity variance estimators in meta‐analysis: a review of simulation studies , 2016, Research synthesis methods.

[5]  David J. Spiegelhalter,et al.  Implementing informative priors for heterogeneity in meta‐analysis using meta‐regression and pseudo data , 2016, Statistics in medicine.

[6]  Lara A Kahale,et al.  Three challenges described for identifying participants with missing data in trials reports, and potential solutions suggested to systematic reviewers. , 2016, Journal of clinical epidemiology.

[7]  Ralf Bender,et al.  Methods to estimate the between‐study variance and its uncertainty in meta‐analysis† , 2015, Research synthesis methods.

[8]  Thomas Agoritsas,et al.  Handling trial participants with missing outcome data when conducting a meta-analysis: a systematic survey of proposed approaches , 2015, Systematic Reviews.

[9]  Julian P T Higgins,et al.  An empirical comparison of heterogeneity variance estimators in 12 894 meta‐analyses , 2015, Research synthesis methods.

[10]  Lyle C Gurrin,et al.  Meta-analysis of incidence rate data in the presence of zero events , 2015, BMC Medical Research Methodology.

[11]  Gordon H Guyatt,et al.  Addressing continuous data measured with different instruments for participants excluded from trial analysis: a guide for systematic reviewers. , 2014, Journal of clinical epidemiology.

[12]  Xin Sun,et al.  Addressing continuous data for participants excluded from trial analysis: a guide for systematic reviewers. , 2013, Journal of clinical epidemiology.

[13]  Gordon H Guyatt,et al.  Combining follow-up and change data is valid in meta-analyses of continuous outcomes: a meta-epidemiological study. , 2013, Journal of clinical epidemiology.

[14]  Michael Borenstein,et al.  Meta-Analysis and Subgroups , 2013, Prevention Science.

[15]  Simon G Thompson,et al.  Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews , 2012, International journal of epidemiology.

[16]  Judith Anzures-Cabrera,et al.  Expressing findings from meta‐analyses of continuous outcomes in terms of risks , 2011, Statistics in medicine.

[17]  Mark C Simmonds,et al.  Meta‐analysis of time‐to‐event data: a comparison of two‐stage methods , 2011, Research synthesis methods.

[18]  Richard D Riley,et al.  Interpretation of random effects meta-analyses , 2011, BMJ : British Medical Journal.

[19]  Hannah R Rothstein,et al.  A basic introduction to fixed‐effect and random‐effects models for meta‐analysis , 2010, Research synthesis methods.

[20]  Ingram Olkin,et al.  Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta‐analysis with zero cells , 2009, Statistics in medicine.

[21]  David J Spiegelhalter,et al.  A re-evaluation of random-effects meta-analysis , 2009, Journal of the Royal Statistical Society. Series A,.

[22]  Julian P T Higgins,et al.  Meta-analysis of skewed data: Combining results reported on log-transformed or raw scales , 2008, Statistics in medicine.

[23]  Ian R White,et al.  Imputation methods for missing outcome data in meta-analysis of clinical trials , 2008, Clinical trials.

[24]  Douglas G. Altman,et al.  Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta‐Analysis , 2008 .

[25]  S. Sharp,et al.  Analysing the Relationship Between Treatment Benefit and Underlying Risk: Precautions and Recommendations , 2008 .

[26]  Jonathan J Deeks,et al.  Much ado about nothing: a comparison of the performance of meta‐analytical methods with rare events , 2007, Statistics in medicine.

[27]  Jesse A Berlin,et al.  Meta-analytic methods for pooling rates when follow-up duration varies: a case study , 2004, BMC medical research methodology.

[28]  Julian P T Higgins,et al.  Controlling the risk of spurious findings from meta‐regression , 2004, Statistics in medicine.

[29]  Alexander J Sutton,et al.  What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. , 2004, Statistics in medicine.

[30]  D. Spiegelhalter,et al.  Bayesian Approaches to Clinical Trials and Health-Care Evaluation: Spiegelhalter/Clinical Trials and Health-Care Evaluation , 2004 .

[31]  Kurex Sidik,et al.  A simple confidence interval for meta‐analysis , 2002, Statistics in medicine.

[32]  Jonathan J Deeks,et al.  Issues in the selection of a summary statistic for meta‐analysis of clinical trials with binary outcomes , 2002, Statistics in medicine.

[33]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[34]  S. Thompson,et al.  How should meta‐regression analyses be undertaken and interpreted? , 2002, Statistics in medicine.

[35]  Harold I Feldman,et al.  Individual patient‐ versus group‐level data meta‐regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head , 2002, Statistics in medicine.

[36]  J. Hartung,et al.  A refined method for the meta‐analysis of controlled clinical trials with binary outcome , 2001, Statistics in medicine.

[37]  Christian Gluud,et al.  Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses , 2001, Annals of Internal Medicine.

[38]  Alex J. Sutton,et al.  Bayesian methods in meta-analysis and evidence synthesis , 2001 .

[39]  Steff Lewis,et al.  Forest plots: trying to see the wood and the trees , 2001, BMJ : British Medical Journal.

[40]  C. DiGuiseppi,et al.  Interventions for promoting smoke alarm ownership and function. , 2001, The Cochrane database of systematic reviews.

[41]  S. Chinn.  A simple method for converting an odds ratio to effect size for use in meta-analysis. , 2000, Statistics in medicine.

[42]  Andrew Thomas,et al.  WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..

[43]  I Olkin,et al.  Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. , 2000, Statistics in medicine.

[44]  S Greenland,et al.  Random-effects meta-analyses are not always conservative. , 1999, American journal of epidemiology.

[45]  S. Sharp,et al.  Explaining heterogeneity in meta-analysis: a comparison of methods. , 1997, Statistics in medicine.

[46]  J J Deeks,et al.  Systematic reviews of published evidence: miracles or minefields? , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[47]  S G Thompson,et al.  Investigating underlying risk as a source of heterogeneity in meta-analysis. , 1997, Statistics in medicine.

[48]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[49]  D G Altman,et al.  Statistics Notes: Detecting skewness from summary information , 1996, BMJ.

[50]  M. McIntosh,et al.  The population risk as an explanatory variable in research synthesis of clinical trials. , 1996, Statistics in medicine.

[51]  D J Spiegelhalter,et al.  Bayesian approaches to random-effects meta-analysis: a comparative study. , 1995, Statistics in medicine.

[52]  V Hasselblad,et al.  Meta-analytic Tools for Medical Decision Making: A Practical Guide , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[53]  A Whitehead,et al.  A meta-analysis of clinical trials involving different classifications of response into ordered categories. , 1994, Statistics in medicine.

[54]  M. Bracken,et al.  Clinically useful measures of effect in binary analyses of randomized trials. , 1994, Journal of clinical epidemiology.

[55]  S Greenland,et al.  Meta‐analysis of Epidemiologic Dose‐Response Data , 1993, Epidemiology.

[56]  R Peto,et al.  Large-scale randomized evidence: large, simple trials and overviews of trials. , 1993, Annals of the New York Academy of Sciences.

[57]  S. Greenland,et al.  Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. , 1992, American journal of epidemiology.

[58]  G H Guyatt,et al.  A Consumer's Guide to Subgroup Analyses , 1992, Annals of Internal Medicine.

[59]  J. Wittes,et al.  Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. , 1991, JAMA.

[60]  S Greenland,et al.  Quantitative methods in the review of epidemiologic literature. , 1987, Epidemiologic reviews.

[61]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[62]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[63]  J M Robins,et al.  Estimation of a common effect parameter from sparse follow-up data. , 1985, Biometrics.

[64]  H. Morgenstern.  Uses of ecologic analysis in epidemiologic research. , 1982, American journal of public health.

[65]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.